Estradiol/progesterone: Completed Phase III enrollment

TherapeuticsMD Inc. (NYSE-M:TXMD), Boca Raton, Fla. Product: Estradiol/progesterone ( TX-001HR) (formerly TX 12-001-HR) Business: Endocrine/Metabolic Molecular target: NA Description: Oral combinatio...